| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f36a9169796a45cc3dad3d1db737b92c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-00042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-00051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-02 |
| filingDate |
2018-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10ea022b52554f1462380955b2bb3e15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd09747575bd933da086205ed0cfbe73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0f7f1911659db2af7379618ddd3974e |
| publicationDate |
2018-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2018134110-A |
| titleOfInvention |
Drug delivery particle and method for producing the same |
| abstract |
The present invention provides a method for easily including a nucleic acid, peptide and / or low molecular weight compound in a hollow capsid while maintaining the initial infectious activity of the virus. A method for producing a drug delivery particle includes a step of mixing a hollow capsid or hollow particle and a drug containing a nucleic acid, a peptide and / or a low molecular weight compound in a solution containing 0.1 to 20% surfactant. Holding the mixed liquid at −5 to 50 ° C. to introduce the drug into the hollow capsid or hollow particles. [Selection figure] None |
| priorityDate |
2011-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |